South Korea · Delayed Price · Currency is KRW HLscience Statistics
Total Valuation
HLscience has a market cap or net worth of KRW 26.99 billion. The enterprise value is 2.98 billion.
| Market Cap | 26.99B |
| Enterprise Value | 2.98B |
Important Dates
The next estimated earnings date is Friday, November 13, 2026.
| Earnings Date | Nov 13, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
HLscience has 5.09 million shares outstanding. The number of shares has increased by 0.03% in one year.
| Current Share Class | 5.09M |
| Shares Outstanding | 5.09M |
| Shares Change (YoY) | +0.03% |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 68.72% |
| Owned by Institutions (%) | n/a |
| Float | 1.59M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 2.59 |
| PB Ratio | 0.34 |
| P/TBV Ratio | 0.35 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 0.29 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 14.74
| Current Ratio | 14.74 |
| Quick Ratio | 12.63 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -13.36% and return on invested capital (ROIC) is -18.26%.
| Return on Equity (ROE) | -13.36% |
| Return on Assets (ROA) | -7.26% |
| Return on Invested Capital (ROIC) | -18.26% |
| Return on Capital Employed (ROCE) | -12.80% |
| Weighted Average Cost of Capital (WACC) | 9.04% |
| Revenue Per Employee | 137.36M |
| Profits Per Employee | -146.75M |
| Employee Count | 76 |
| Asset Turnover | 0.12 |
| Inventory Turnover | 2.38 |
Taxes
In the past 12 months, HLscience has paid 87.48 million in taxes.
| Income Tax | 87.48M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -53.14% in the last 52 weeks. The beta is 0.87, so HLscience's price volatility has been lower than the market average.
| Beta (5Y) | 0.87 |
| 52-Week Price Change | -53.14% |
| 50-Day Moving Average | 5,375.20 |
| 200-Day Moving Average | 7,092.70 |
| Relative Strength Index (RSI) | 44.46 |
| Average Volume (20 Days) | 1,460 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, HLscience had revenue of KRW 10.44 billion and -11.15 billion in losses. Loss per share was -2,189.99.
| Revenue | 10.44B |
| Gross Profit | 3.25B |
| Operating Income | -10.06B |
| Pretax Income | -11.13B |
| Net Income | -11.15B |
| EBITDA | -7.72B |
| EBIT | -10.06B |
| Loss Per Share | -2,189.99 |
Balance Sheet
The company has 24.16 billion in cash and no debt, with a net cash position of 24.16 billion or 4,743.49 per share.
| Cash & Cash Equivalents | 24.16B |
| Total Debt | n/a |
| Net Cash | 24.16B |
| Net Cash Per Share | 4,743.49 |
| Equity (Book Value) | 78.38B |
| Book Value Per Share | 15,362.72 |
| Working Capital | 27.41B |
Cash Flow
In the last 12 months, operating cash flow was -6.38 billion and capital expenditures -485.22 million, giving a free cash flow of -6.86 billion.
| Operating Cash Flow | -6.38B |
| Capital Expenditures | -485.22M |
| Depreciation & Amortization | 2.34B |
| Net Borrowing | n/a |
| Free Cash Flow | -6.86B |
| FCF Per Share | -1,347.22 |
Margins
Gross margin is 31.12%, with operating and profit margins of -96.34% and -106.83%.
| Gross Margin | 31.12% |
| Operating Margin | -96.34% |
| Pretax Margin | -106.62% |
| Profit Margin | -106.83% |
| EBITDA Margin | -73.97% |
| EBIT Margin | -96.34% |
| FCF Margin | n/a |
Dividends & Yields
HLscience does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -0.03% |
| Shareholder Yield | -0.03% |
| Earnings Yield | -41.32% |
| FCF Yield | -25.42% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on December 29, 2020. It was a forward split with a ratio of 1.05.
| Last Split Date | Dec 29, 2020 |
| Split Type | Forward |
| Split Ratio | 1.05 |
Scores
HLscience has an Altman Z-Score of 13.45 and a Piotroski F-Score of 1.
| Altman Z-Score | 13.45 |
| Piotroski F-Score | 1 |